4197. Misbranding of Hyzorbis tablets.   U. S. v. 7 Bottles, etc.    (F. D. C. No.
35340.   Sample No. 55799-L.)    .
LIBEL FILED:    June 29, 1953, Western District of Pennsylvania.:
*See also Nos. 4189, 4190, 4192-4196.
Corp. & Co., Inc., from Syracuse, N. Y.
PRODUCT : 7 1,000-tablet bottles and 5 2,000-tablet bottles of EyzorUs tablet*
at Pittsburgh, Pa.
LABEL, ' IN PABT : (Bottle) "Hy-Zorbis Gastro-Enteric Sedative * * *
Hyzorbis represents in each tablet Extract Hyoscyamus ?'gr. (16.2 mg.)
(containing 0.0003875 gr. total alkaloids of Hyoscyamus), Bismuth Subcarbbn-
ate 2 gr. (129.6 mg.), Magnesium Trisilicate 2 gr. (129.6 mg.), Calcium Carbon-
ate 1 gr. (64.8 mg.), Magnesium Carbonate 1 gr. (64.8 mg.) and Diastase ? gr*
(16.2 mg.)."
NATURE OF CHARGE: Misbranding, Section 502 (a), certain statements on the
bottle label of the article were false and misleading. The statements repre-
sented and suggested that the article was an adequate and effective treatment
for disturbances of the gastrointestinal tract, such as gastroenteritis, mucous
colitis, dysentery, diarrhea, and peptic and duodenal ulcers. The article was-
not an adequate and effective treatment for such conditions.
DISPOSITION : August 6, 1953. Default decree of condemnation. The court
ordered that the product be delivered to a county institution.